l‐Cysteine Alleviates Peritoneal Fibrosis by Repressing PKM2 in Peritoneal Mesothelial Cells

Peritoneal fibrosis is one of the main causes of peritoneal dysfunction and withdrawal of patients from peritoneal dialysis (PD). Our previous study has shown that high‐glucose dialysis solution promotes glycolysis in peritoneal mesothelial cells, leading to mesothelial‐to‐mesenchymal transition (MMT) and peritoneal fibrosis. However, the molecular mechanisms remain unclear. Using single‐cell RNA sequencing (scRNA‐seq) analysis of cells from the effluent of patients undergoing PD from our previous study, we found that pyruvate kinase isozymes M2 (PKM2), a key rate‐limiting enzyme of glucose metabolism, was significantly upregulated in the mesothelial cells of patients with long‐term peritoneal dialysis (LPD). Using co‐immunoprecipitation, chromatin immunoprecipitation assay, and gene silencing techniques, we revealed that PKM2 promotes the expression of transcription factor SNAI2 by acetylating histone H3K9 (H3K9ac), thereby promoting the occurrence of MMT and hence peritoneal fibrosis. l‐cysteine, a known PKM2 inhibitor, blocked these responses and prevented PD‐induced peritoneal fibrosis. These results could provide a novel therapeutic strategy for treating peritoneal fibrosis.

• Publication year

  2025

• Venue

  The FASEB Journal

• Publication date

  2025-06-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1096/fj.202500229RPMID 40497367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement.

  2023cited by this paper
• Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?

  2022cited by this paper
• PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling

  2022cited by this paper
• Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?

  2021cited by this paper
• Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis

  2020cited by this paper
• Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2

  2020cited by this paper
• CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis–Driven Hepatocarcinogenesis via ERK‐Dependent PKM2 Nuclear Relocalization and Activation

  2020cited by this paper
• Gene Regulatory Effect of Pyruvate Kinase M2 is Involved in Renal Inflammation in Type 2 Diabetic Nephropathy.

  2020cited by this paper
• Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis

  2020cited by this paper
• Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis

  2020cited by this paper
• Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment

  2020cited by this paper
• PKM2, function and expression and regulation

  2019cited by this paper
• Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis

  2019cited by this paper
• Mechanistic and Structural Insights into Cysteine-Mediated Inhibition of Pyruvate Kinase Muscle Isoform 2.

  2019cited by this paper
• How the Warburg effect supports aggressiveness and drug resistance of cancer cells?

  2018cited by this paper
• Metabolic Kinases Moonlighting as Protein Kinases.

  2018cited by this paper
• Effects of the Usage of l-Cysteine (l-Cys) on Human Health

  2018cited by this paper
• Functional molecules in mesothelial‐to‐mesenchymal transition revealed by transcriptome analyses

  2018cited by this paper
• Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors.

  2017cited by this paper
• PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis

  2017cited by this paper
• Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.

  2016cited by this paper
• L-Cysteine metabolism and its nutritional implications.

  2016cited by this paper
• Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2

  2016cited by this paper
• The Current State of Peritoneal Dialysis.

  2016cited by this paper
• l-cysteine reversibly inhibits glucose-induced biphasic insulin secretion and ATP production by inactivating PKM2

  2015cited by this paper
• Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor

  2015cited by this paper
• Mesothelial cells in tissue repair and fibrosis

  2015cited by this paper
• High-Dialysate-Glucose-Induced Oxidative Stress and Mitochondrial-Mediated Apoptosis in Human Peritoneal Mesothelial Cells

  2014cited by this paper
• Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial–mesenchymal transition

  2014cited by this paper
• N-Acetylcysteine protects the peritoneum from the injury induced by hypertonic dialysis solution.

  2012cited by this paper
• PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.

  2012cited by this paper
• L-Cysteine Administration Attenuates Pancreatic Fibrosis Induced by TNBS in Rats by Inhibiting the Activation of Pancreatic Stellate Cell

  2012cited by this paper
• Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2

  2011cited by this paper
• Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

  2011cited by this paper
• EFFECT OF ORAL N-ACETYLCYSTEINE TREATMENT ON PLASMA INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PERITONEAL DIALYSIS PATIENTS: A PLACEBO-CONTROLLED STUDY

  2010cited by this paper
• Can N-Acetylcysteine Preserve Peritoneal Function and Morphology in Encapsulating Peritoneal Sclerosis?

  2009cited by this paper
• Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.

  2003cited by this paper
• L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation.

  2003cited by this paper
• High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells.

  2001cited by this paper
• High glucose–induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells

  2001cited by this paper
• Transition

  1988cited by this paper

• No citing papers are available for this paper.